AC
INBX

Athanor Capital’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Athanor Capital’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,573
Closed -$217K – 1141
2020
Q4 		$217K Buy
+6,573
New +$175K ﹤0.01% 643

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Athanor Capital's INBX Position: Q1 2021 in Review

Athanor Capital sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2021, closing a stake of 6,573 shares — an estimated $217K sold.

Athanor Capital first reported a position in INBX in Q4 2020 and held it in 1 quarter. The position peaked at $217K in Q4 2020. 55 funds tracked by Wall St. Rank hold INBX as of Q1 2021.

  • Athanor Capital reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Athanor Capital sold 6,573 Inhibrx, Inc. Common Stock shares in Q1 2021, an estimated $217K.
  • Athanor Capital first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Athanor Capital's Inhibrx, Inc. Common Stock position peaked at $217K in Q4 2020.
  • 55 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.